Cane Capital Partners LLC Buys New Position in Humana Inc. $HUM

Cane Capital Partners LLC bought a new position in shares of Humana Inc. (NYSE:HUM) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,299 shares of the insurance provider’s stock, valued at approximately $225,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Montag A & Associates Inc. raised its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC grew its stake in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac acquired a new position in shares of Humana in the 4th quarter valued at about $27,000. Reflection Asset Management acquired a new position in shares of Humana in the 4th quarter valued at about $29,000. Finally, Rosenberg Matthew Hamilton lifted its position in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Up 3.2%

HUM stock opened at $409.92 on Thursday. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $414.82. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $314.71 and its 200-day moving average is $248.64. The firm has a market cap of $49.22 billion, a P/E ratio of 43.84, a P/E/G ratio of 2.26 and a beta of 0.71.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter last year, the company posted $11.58 EPS. The company’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts anticipate that Humana Inc. will post 9.04 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s payout ratio is currently 37.86%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HUM. TD Cowen lifted their price target on Humana from $173.00 to $211.00 and gave the company a “hold” rating in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. William Blair assumed coverage on shares of Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating for the company. Evercore boosted their target price on shares of Humana from $250.00 to $370.00 in a research report on Thursday, June 11th. Finally, Cantor Fitzgerald restated a “neutral” rating on shares of Humana in a research note on Thursday, June 11th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $293.09.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.